-- 加拿大皇家银行资本市场（RBC Capital Markets）周一发布的研究报告指出，Pinterest (PINS) 对 GPU 的投资以及其专有模型改进计划，是该股近期“最引人注目”的平台增强机会，因为它有望提升用户参与度和精准定位能力。 分析师写道，由于转化率的提升，大型客户带来的不利影响有所减弱，Pinterest 第一季度业绩“好于预期”。Performance Plus 业务贡献了漏斗底部收入的 30%，而基础设施投资和收购有望在下半年缓解不利影响。 该券商表示，第一季度营收超预期部分得益于大型零售广告商的出色表现，因为人工智能驱动的平台改进在季度后期开始抵消不利影响。 报告指出，Pinterest 预计第二季度全球增长将受到以下因素的制约：对国际市场架构进行审慎的管理和组织调整；以及美国关税导致跨境支出增加。 该券商重申了对该股的“与行业持平”评级，并将目标价从 17 美元上调至 23 美元。
Price: $23.26, Change: $+2.41, Percent Change: +11.56%
American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%
MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.